Glenmark Pharmaceuticals - VAI
FDA Inspections Database

Glenmark Pharmaceuticals - VAI

FDA Inspections Database

U.S. FDA inspection classifications and citation records from the official FDA inspection database.

VAI · Voluntary Action Indicated India
  • Total Records 12
  • Latest Inspection 2019-03-15
  • Data Source U.S. FDA
  • Last Updated 2019-05-13

25

All
View

10

NAI
View

12

VAI
View

3

OAI
View
Company Overview

Company

Glenmark Pharmaceuticals - VAI

Country

India

Social Profiles

Company Snapshot

Glenmark Pharmaceuticals - VAI

Glenmark House, B. D. Sawant Marg, Chakala, Off Western Express Highway, Andheri (E), Mumbai - 400 099

India

www.glenmarkpharma.com/ india_marketing@glenmarkpharma.com View on Map
FDA Inspections Timeline (12 records)
2019
15 Mar
Voluntary Action Indicated VAI

Legal Name

Glenmark Pharmaceuticals Limited

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

Yes

Inspection End Date

2019-03-15

FMD Date

2019-05-13

Fiscal Year

2019

State

Colvale, India

Location

Colvale, , India

Inspection Info

Fiscal Year: 2019
Citations: Yes

2018
17 Aug
Voluntary Action Indicated VAI

Legal Name

Glenmark Pharmaceuticals Limited

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2018-08-17

FMD Date

2018-10-05

Fiscal Year

2018

State

Aurangabad, India

Location

Aurangabad, , India

Inspection Info

Fiscal Year: 2018
Citations: No

2018
24 May
Voluntary Action Indicated VAI

Legal Name

Glenmark Pharmaceuticals Limited

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2018-05-24

FMD Date

2018-10-24

Fiscal Year

2018

State

Dhar, India

Location

Dhar, , India

Inspection Info

Fiscal Year: 2018
Citations: No

2017
11 Nov
Voluntary Action Indicated VAI

Legal Name

Glenmark Pharmaceuticals Limited

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

Yes

Inspection End Date

2017-11-11

FMD Date

2018-03-16

Fiscal Year

2018

State

Solan, India

Location

Solan, , India

Inspection Info

Fiscal Year: 2018
Citations: Yes

2016
17 Jun
Voluntary Action Indicated VAI

Legal Name

Glenmark Pharmaceuticals Limited

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2016-06-17

FMD Date

2017-05-04

Fiscal Year

2016

State

Aurangabad, India

Location

Aurangabad, , India

Inspection Info

Fiscal Year: 2016
Citations: No

2016
26 Feb
Voluntary Action Indicated VAI

Legal Name

Glenmark Pharmaceuticals Limited

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

Yes

Inspection End Date

2016-02-26

FMD Date

2016-06-07

Fiscal Year

2016

State

Dhar, India

Location

Dhar, , India

Inspection Info

Fiscal Year: 2016
Citations: Yes

2015
24 Jul
Voluntary Action Indicated VAI

Legal Name

Glenmark Pharmaceuticals Limited

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2015-07-24

FMD Date

2015-09-09

Fiscal Year

2015

State

Dhar, India

Location

Dhar, , India

Inspection Info

Fiscal Year: 2015
Citations: No

2015
29 May
Voluntary Action Indicated VAI

Legal Name

Glenmark Pharmaceuticals Limited

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2015-05-29

FMD Date

2016-01-21

Fiscal Year

2015

State

Solan, India

Location

Solan, , India

Inspection Info

Fiscal Year: 2015
Citations: No

2013
19 Jul
Voluntary Action Indicated VAI

Legal Name

Glenmark Pharmaceuticals Limited

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

Yes

Inspection End Date

2013-07-19

FMD Date

2013-10-21

Fiscal Year

2013

State

Colvale, India

Location

Colvale, , India

Inspection Info

Fiscal Year: 2013
Citations: Yes

2011
12 Oct
Voluntary Action Indicated VAI

Legal Name

Glenmark Pharmaceuticals Limited

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2011-10-12

FMD Date

2012-02-21

Fiscal Year

2012

State

Colvale, India

Location

Colvale, , India

Inspection Info

Fiscal Year: 2012
Citations: No

2009
20 Nov
Voluntary Action Indicated VAI

Legal Name

Glenmark Pharmaceuticals Limited

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2009-11-20

FMD Date

2010-03-22

Fiscal Year

2010

State

Colvale, India

Location

Colvale, , India

Inspection Info

Fiscal Year: 2010
Citations: No

2009
13 Nov
Voluntary Action Indicated VAI

Legal Name

Glenmark Pharmaceuticals Limited

Project Area

Drug Quality Assurance

Product Type

Drugs

Posted Citations

No

Inspection End Date

2009-11-13

FMD Date

-

Fiscal Year

2010

State

Solan, India

Location

Solan, , India

Inspection Info

Fiscal Year: 2010
Citations: No

Related Databases
  • FDA Inspections
    25 View
  • EDQM CEP
    2 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
Classification Breakdown
12 total
  • VAI (Voluntary Action Indicated)
Official Source

All data is sourced from the official FDA inspection database maintained by the U.S. Food and Drug Administration.

Visit FDA.gov
Record Details Preview

Click "View Details" on any record above to expand full details inline.

Location

Colvale, , India

Inspection Info

Fiscal Year: 2019
Citations: Yes

100% Official Data

Directly from the U.S. FDA inspection database

Regular Updates

Data updated regularly from official sources

Trusted by Professionals

100K+ pharma professionals worldwide

Secure & Reliable

Enterprise-grade security and data protection

FDA inspection data is compiled from publicly available U.S. FDA inspection classification records.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.